Laurus Labs has informed that in furtherance to disclosure dated July 01, 2020 regarding the completion of acquisition of 100% shares of Phekolong Pharmaceuticals, the Company further updated that the name of Phekolong Pharmaceuticals Pty. Ltd., the Wholly Owned Subsidiary of the Company has been changed to Laurus Generics SA (Pty) Ltd, with effect from July 02, 2020.
The above information is a part of company’s filings submitted to BSE.